Politician trade (House)

HCA Healthcare (HCA)Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a purchase of HCA Healthcare in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
43 days
Disclosure lag
Traded
May 15, 2025
Disclosed
Jun 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 26, 2011Insider10% owner purchased ~$19K of HCA shares in the open market
  2. Jan 10, 2012Insider10% owner sold ~$10K of HCA shares in the open market
  3. Jan 13, 2012Insider10% owner purchased ~$11K of HCA shares in the open market
  4. Jan 25, 2012Insider · 1 personInsiders: 3 purchases (~$8K), 3 sales (~$8K)
  5. Feb 1, 2012Insider10% owner sold ~$3.7K of HCA shares in the open market
  6. Feb 2, 2012Insider10% owner purchased ~$3.7K of HCA shares in the open market
  7. Feb 3, 2012Insider10% owner purchased ~$26 of HCA shares in the open market
  8. Feb 7, 2012Insider10% owner purchased ~$928 of HCA shares in the open market
  9. Feb 13, 2012Insider10% owner purchased ~$28 of HCA shares in the open market
  10. Feb 14, 2012Insider · 1 personInsiders: 2 sales (~$831)
  11. Feb 17, 2012Insider10% owner sold ~$25 of HCA shares in the open market
  12. Feb 22, 2012Insider · 1 personInsiders: 1 purchase (~$5K), 1 sale (~$5K)
  13. Mar 8, 2012Insider · 1 personInsiders: 1 purchase (~$40K), 4 sales (~$40K)
  14. Mar 9, 2012Insider10% owner purchased ~$51 of HCA shares in the open market
  15. Mar 15, 2012Insider10% owner sold ~$51 of HCA shares in the open market
  16. Mar 16, 2012Insider10% owner sold ~$633 of HCA shares in the open market
  17. Mar 19, 2012Insider10% owner purchased ~$630 of HCA shares in the open market
  18. Apr 3, 2012Insider · 1 personInsiders: 2 sales (~$11K)
  19. Oct 29, 2024Congress · 1 personMembers of Congress: 2 purchases
  20. Dec 27, 2024CongressDisclosed sale of HCA — reported range $1,001 - $15,000
  21. Feb 25, 2025CongressDisclosed sale of HCA — reported range $1,001 - $15,000
  22. Apr 7, 2025CongressDisclosed sale of HCA — reported range $1,001 - $15,000
  23. May 13, 2025InsiderOfficer sold ~$5.8M of HCA shares in the open market
  24. May 15, 2025 · this disclosureCongressDisclosed purchase of HCA — reported range $1,001 - $15,000

What came next

  1. May 15, 2025CongressDisclosed purchase of HCA — reported range $1,001 - $15,000
  2. Aug 19, 2025CongressDisclosed purchase of HCA — reported range $1,001 - $15,000
  3. Sep 8, 2025InsiderOfficer sold ~$1.61M of HCA shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for HCA Healthcare

For HCA Healthcare, OQRO holds 3 Congress trade reports and 29 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCA page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

Other disclosures at HCA Healthcare

Everything OQRO holds on this company is on its HCA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data